CNSX:ORTH

Ortho Regenerative Technologies Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2,500 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Ortho Regenerative Technologies (CNSX:ORTH) Vs. VMD, TMD, HTL, PTQ, HSM, and PHM

Should you be buying ORTH stock or one of its competitors? Companies in the industry of "medical devices" are considered alternatives and competitors to Ortho Regenerative Technologies, including Viemed Healthcare (VMD), Titan Medical (TMD), Hamilton Thorne (HTL), Protech Home Medical (PTQ), Helius Medical Technologies (HSM), and Protech Home Medical (PHM).

Ortho Regenerative Technologies (CNSX:ORTH) and Viemed Healthcare (TSE:VMD) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Earnings and Valuation

This table compares Ortho Regenerative Technologies and Viemed Healthcare's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ortho Regenerative TechnologiesN/AN/AN/AN/AN/A
Viemed HealthcareC$131.31 million3.87C$30.86 millionC$0.7816.49

Viemed Healthcare has higher revenue and earnings than Ortho Regenerative Technologies.

Analyst Ratings

This is a summary of current ratings and target prices for Ortho Regenerative Technologies and Viemed Healthcare, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ortho Regenerative Technologies0000N/A
Viemed Healthcare01002.00

Profitability

This table compares Ortho Regenerative Technologies and Viemed Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ortho Regenerative TechnologiesN/AN/AN/A
Viemed HealthcareN/AN/AN/A

Summary

Viemed Healthcare beats Ortho Regenerative Technologies on 1 of the 1 factors compared between the two stocks.

Ortho Regenerative Technologies (CNSX:ORTH) and Titan Medical (TSE:TMD) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Earnings and Valuation

This table compares Ortho Regenerative Technologies and Titan Medical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ortho Regenerative TechnologiesN/AN/AN/AN/AN/A
Titan MedicalC$20 million12.43C$-39,538,525.00C($0.36)-6.29

Ortho Regenerative Technologies has higher earnings, but lower revenue than Titan Medical.

Analyst Ratings

This is a summary of current ratings and target prices for Ortho Regenerative Technologies and Titan Medical, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ortho Regenerative Technologies0000N/A
Titan Medical0000N/A

Profitability

This table compares Ortho Regenerative Technologies and Titan Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ortho Regenerative TechnologiesN/AN/AN/A
Titan MedicalN/AN/AN/A

Summary

Titan Medical beats Ortho Regenerative Technologies on 1 of the 1 factors compared between the two stocks.

Ortho Regenerative Technologies (CNSX:ORTH) and Hamilton Thorne (CVE:HTL) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Earnings and Valuation

This table compares Ortho Regenerative Technologies and Hamilton Thorne's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ortho Regenerative TechnologiesN/AN/AN/AN/AN/A
Hamilton ThorneC$38.36 million6.35C$968,653.00C$0.01251.43

Hamilton Thorne has higher revenue and earnings than Ortho Regenerative Technologies.

Analyst Ratings

This is a summary of current ratings and target prices for Ortho Regenerative Technologies and Hamilton Thorne, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ortho Regenerative Technologies0000N/A
Hamilton Thorne00403.00

Hamilton Thorne has a consensus price target of C$1.87, suggesting a potential upside of 6.25%.

Profitability

This table compares Ortho Regenerative Technologies and Hamilton Thorne's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ortho Regenerative TechnologiesN/AN/AN/A
Hamilton ThorneN/AN/AN/A

Summary

Hamilton Thorne beats Ortho Regenerative Technologies on 2 of the 2 factors compared between the two stocks.

Ortho Regenerative Technologies (CNSX:ORTH) and Protech Home Medical (CVE:PTQ) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Earnings and Valuation

This table compares Ortho Regenerative Technologies and Protech Home Medical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ortho Regenerative TechnologiesN/AN/AN/AN/AN/A
Protech Home MedicalC$82.22 million3.16C$-4,288,908.00C($0.04)-60.53

Ortho Regenerative Technologies has higher earnings, but lower revenue than Protech Home Medical.

Analyst Ratings

This is a summary of current ratings and target prices for Ortho Regenerative Technologies and Protech Home Medical, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ortho Regenerative Technologies0000N/A
Protech Home Medical00503.00

Protech Home Medical has a consensus price target of C$2.58, suggesting a potential upside of 12.32%.

Profitability

This table compares Ortho Regenerative Technologies and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ortho Regenerative TechnologiesN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Summary

Protech Home Medical beats Ortho Regenerative Technologies on 2 of the 2 factors compared between the two stocks.

Ortho Regenerative Technologies (CNSX:ORTH) and Helius Medical Technologies (TSE:HSM) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Earnings and Valuation

This table compares Ortho Regenerative Technologies and Helius Medical Technologies' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ortho Regenerative TechnologiesN/AN/AN/AN/AN/A
Helius Medical TechnologiesC$661,000.0077.72C$-27,269,800.00C($11.80)-1.88

Ortho Regenerative Technologies has higher earnings, but lower revenue than Helius Medical Technologies.

Analyst Ratings

This is a summary of current ratings and target prices for Ortho Regenerative Technologies and Helius Medical Technologies, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ortho Regenerative Technologies0000N/A
Helius Medical Technologies0000N/A

Profitability

This table compares Ortho Regenerative Technologies and Helius Medical Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ortho Regenerative TechnologiesN/AN/AN/A
Helius Medical TechnologiesN/AN/AN/A

Summary

Helius Medical Technologies beats Ortho Regenerative Technologies on 1 of the 1 factors compared between the two stocks.

Ortho Regenerative Technologies (CNSX:ORTH) and Protech Home Medical (CVE:PHM) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Valuation and Earnings

This table compares Ortho Regenerative Technologies and Protech Home Medical's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ortho Regenerative TechnologiesN/AN/AN/AN/AN/A
Protech Home MedicalC$77.14 million0.62C$833,022.00C$0.0057.50

Protech Home Medical has higher revenue and earnings than Ortho Regenerative Technologies.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Ortho Regenerative Technologies and Protech Home Medical, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ortho Regenerative Technologies0000N/A
Protech Home Medical0000N/A

Profitability

This table compares Ortho Regenerative Technologies and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ortho Regenerative TechnologiesN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Summary

Protech Home Medical beats Ortho Regenerative Technologies on 1 of the 1 factors compared between the two stocks.


Ortho Regenerative Technologies Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
VMD
Viemed Healthcare
0.3$12.86flatC$508.77 millionC$131.31 million16.49News Coverage
TMD
Titan Medical
0.8$2.27flatC$248.62 millionC$20 million-6.29Gap Down
Hamilton Thorne logo
HTL
Hamilton Thorne
1.2$1.76flatC$165.83 millionC$38.36 million251.43Analyst Report
Analyst Revision
News Coverage
Protech Home Medical logo
PTQ
Protech Home Medical
1.2$2.30flatC$94.56 millionC$82.22 million-60.53
HSM
Helius Medical Technologies
0.5$22.23flatC$51.37 millionC$661,000.00-1.88
PHM
Protech Home Medical
0.5$0.12flatC$50.12 millionC$77.14 million57.50Gap Up
ASG
Aurora Spine
0.6$0.84flatC$8.31 millionC$8.84 million-44.21Gap Up
BLO
Cannabix Technologies
0.5N/AN/AC$0.00N/A0.00News Coverage
Gap Up
Smith & Nephew logo
SNN
Smith & Nephew
0.6N/AN/A$0.00N/A0.00News Coverage
VMD
Viemed Healthcare
0.5$4.95flatC$0.00N/A0.00Gap Up
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.